New cancer vaccine Out
May 3rd, 2010 - 9:46 pm ICT by Pen Men At WorkMay 3, 2010 (Pen Men at Work): The Food and Drug Administration (FDA) of America has supplied its approval to the latest prostate cancer vaccine, Provenge. It has been manufactured by the biotech company, Dendreon, and will lend a hand to the patients to live a little longer. Dendreon first presented its vaccine to the FDA for endorsement in 2006.
The vaccine is produced by revealing patients’ immune cells outside the body to prostate cancer cells. The uncovered immune cells are then inserted into patients with the mission of priming the patients’ immune structure to assault the cancer.
Prostate cancer grows in a gland in the male reproductive system, from where it can disseminate to the bones and lymph nodes. It normally plagues men after 50 years of age and is the second-most frequent cancer after skin.
Currently, prostate cancer is taken care of by utilizing radiation, by surgical procedure to extract the gland, by drugs to diminish the levels of the hormone testosterone that nourishes the tumors, and also by the chemotherapy drug, Taxotere, which lengthens the lives of patients by some months.
The other accepted vaccines for cervical cancer, measles or polio are provided as a precautionary measure. The new cancer vaccine will make a patient’s immune system take care of the cancer by assaulting the tumor.
Dr. V. M. Katoch, secretary of department of health research, has declared that this vaccine has supplied optimism to all the cancer patients. The scientists are now functioning on similar vaccines for cancers of the breast, lung, skin and lymph nodes.
- Dendreon Makes New Breakthrough In Fight Against Cancer - Apr 30, 2010
- First prostrate cancer vaccine a major breakthrough, says Oncologist - May 09, 2010
- FDA Authorizes A New Prostate Cancer Drug - Jun 18, 2010
- Vaccines to boost immunity where it counts - Jan 23, 2012
- Molecular predictor of metastatic prostate cancer identified - Feb 03, 2011
- New Cancer Vaccine Approved By FDA - May 03, 2010
- FDA Sanctions New Drug For Prostrate Cancer Treatment - Jun 18, 2010
- How to manipulate 'TRAP' gene for treating cancer - Dec 30, 2009
- Vaccine that stops all tumours in their tracks to be available by 2013-end - Apr 15, 2011
- Oral vaccines are 'alternative to jab' - Feb 11, 2011
- This jab could revolutionise cancer treatment - Apr 15, 2011
- How breast cancer cells dodge immune system and survive - Feb 02, 2011
- Novel immune therapy for pancreatic cancer discovered - Mar 25, 2011
- Cuba launches world's first lung cancer retardant - Sep 07, 2011
- Scientists identify molecules that help propel cancer metastasis - Apr 09, 2011
Tags: biotech company, cancer patients, cancer prostate, cervical cancer, chemotherapy drug, dendreon, food and drug administration, food and drug administration fda, frequent cancer, hormone testosterone, immune cells, male reproductive system, men at work, new cancer vaccine, pen men, precautionary measure, prostate cancer, prostate cancer cells, prostate cancer vaccine, taxotere